Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Retained earnings	Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2022		73,847,596
Beginning balance at Dec. 31, 2022	$ 1,126,366	$ 74	$ 942,946	$ 183,503	$ (157)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	50,099			50,099
Share-based compensation	7,974		7,974
Issuance of common stock - vesting of restricted stock units (in shares)		269,755
Exercise of stock options (in shares)		52,765
Exercise of stock appreciation rights (in shares)		1,964
Ending balance at Jun. 30, 2023	1,184,439	$ 74	950,920	233,602	(157)
Ending balance (in shares) at Jun. 30, 2023		74,172,080
Beginning balance (in shares) at Mar. 31, 2023		73,924,212
Beginning balance at Mar. 31, 2023	1,147,410	$ 74	946,768	200,725	(157)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	32,877			32,877
Share-based compensation	4,152		4,152
Issuance of common stock - vesting of restricted stock units (in shares)		246,403
Exercise of stock appreciation rights (in shares)		1,465
Ending balance at Jun. 30, 2023	1,184,439	$ 74	950,920	233,602	(157)
Ending balance (in shares) at Jun. 30, 2023		74,172,080
Beginning balance (in shares) at Dec. 31, 2023		74,372,889
Beginning balance at Dec. 31, 2023	1,267,382	$ 74	960,700	306,622	(14)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	70,278			70,278
Share-based compensation	8,003		8,003
Issuance of common stock - vesting of restricted stock units (in shares)		360,903
Issuance of common stock - vesting of restricted stock units	0	$ 1	(1)
Exercise of stock appreciation rights (in shares)		10,193
Ending balance at Jun. 30, 2024	1,345,663	$ 75	968,702	376,900	(14)
Ending balance (in shares) at Jun. 30, 2024		74,743,985
Beginning balance (in shares) at Mar. 31, 2024		74,399,237
Beginning balance at Mar. 31, 2024	1,309,514	$ 74	964,868	344,586	(14)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	32,314			32,314
Share-based compensation	3,835		3,835
Issuance of common stock - vesting of restricted stock units (in shares)		337,552
Issuance of common stock - vesting of restricted stock units	0	$ 1	(1)
Exercise of stock appreciation rights (in shares)		7,196
Ending balance at Jun. 30, 2024	$ 1,345,663	$ 75	$ 968,702	$ 376,900	$ (14)
Ending balance (in shares) at Jun. 30, 2024		74,743,985